VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.
Tatiana V
TV
Petrova
Petri
P
Bono
Wolfgang
W
Holnthoner
Jessica
J
Chesnes
Bronislaw
B
Pytowski
Harri
H
Sihto
Pirjo
P
Laakkonen
Päivi
P
Heikkilä
Heikki
H
Joensuu
Kari
K
Alitalo
D000906:Antibodies; D000918:Antibody Specificity; D001808:Blood Vessels / Q000737:chemistry* / Q000473:pathology; D015152:Blotting, Northern; D015153:Blotting, Western; D045744:Cell Line, Tumor; D002469:Cell Separation; D042783:Endothelial Cells / Q000737:chemistry; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D042601:Lymphatic Vessels / Q000737:chemistry* / Q000473:pathology; D009369:Neoplasms / Q000098:blood supply / Q000737:chemistry* / Q000235:genetics / Q000473:pathology; D012333:RNA, Messenger / Q000032:analysis; D015203:Reproducibility of Results; D020133:Reverse Transcriptase Polymerase Chain Reaction; D040321:Vascular Endothelial Growth Factor Receptor-3 / Q000032:analysis* / Q000235:genetics / Q000276:immunology
D000906:Antibodies; D012333:RNA, Messenger; D040321:Vascular Endothelial Growth Factor Receptor-3